SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-15-117968
Filing Date
2015-04-02
Accepted
2015-04-02 16:34:06
Documents
9
Period of Report
2015-04-02
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d901653d8k.htm 8-K 19708
2 EX-1.1 d901653dex11.htm EX-1.1 153236
3 EX-5.1 d901653dex51.htm EX-5.1 11879
4 EX-99.1 d901653dex991.htm EX-99.1 7956
5 EX-99.2 d901653dex992.htm EX-99.2 7924
6 GRAPHIC g901653ex5_1pg001.jpg GRAPHIC 4723
7 GRAPHIC g901653ex5_1pg002.jpg GRAPHIC 3097
8 GRAPHIC g901653ex99_1pg001.jpg GRAPHIC 18917
9 GRAPHIC g901653ex99_2pg001.jpg GRAPHIC 18965
  Complete submission text file 0001193125-15-117968.txt   265531
Mailing Address 16745 WEST BERNARDO DRIVE Suite 200 San Diego CA 92127
Business Address 16745 WEST BERNARDO DRIVE Suite 200 San Diego CA 92127 (858) 376-2600
Conatus Pharmaceuticals Inc. (Filer) CIK: 0001383701 (see all company filings)

IRS No.: 203183915 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36003 | Film No.: 15748163
SIC: 2834 Pharmaceutical Preparations